16:12 EST 10x Genomics (TXG) sees 2026 revenue $600M-$625M, consensus $611.77M
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide
- Cathie Wood Loads Up on Broadcom and Crypto Stocks, Trims Meta by $8M Ahead of Q4. Here’s Why
- Cathie Wood Doubles Down on High-Potential Biotech Plays
- 10x Genomics: Solid Q4 Rebound but Sustainability Questions Justify Maintaining Hold
- 10x Genomics announces collaboration with Dana-Farber Cancer Institute